4 recruiting, 1 active not recruiting. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 4, Active not recruiting 1 |
| Phase 1 | 3 | Recruiting 2, Active not recruiting 1 |
Follow Ever Supreme Bio Technology Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety And Efficacy Study Of Allogeneic CAR Gamma-Delta T Cells in Subjects With Relapsed/Refractory Solid Tumors HLA-G-CAR.BiTE allogeneic γδ T cells - Solid Tumor | Phase 1 / Phase 2 | Recruiting | Ever Supreme Bio Technology Co., Ltd. | 60 | 2024-09-01 | 2026-09-09 |
| Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients Allogeneic umbilical cord mesenchymal stem cells, Control group - ST Elevation Myocardial Infarction | Phase 2 | Recruiting | Ever Supreme Bio Technology Co., Ltd. | 41 | 2023-09-24 | 2026-09-23 |
| Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Allogeneic umbilical cord mesenchymal stem cells, Control group - Multiple Sclerosis | Phase 1 / Phase 2 | Recruiting | Ever Supreme Bio Technology Co., Ltd. | 41 | 2023-09-08 | 2025-08-07 |
| Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19 Allogeneic umbilical cord mesenchymal stem cells, Controlled normal saline - COVID-19 Infection | Phase 1 / Phase 2 | Active not recruiting | Ever Supreme Bio Technology Co., Ltd. | 75 | 2020-08-05 | 2026-09-23 |
| Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients autologous dendritic cells - GBM | Phase 2 | Recruiting | Ever Supreme Bio Technology Co., Ltd. | 24 | 2019-06-06 | 2026-09-24 |
COVID-19 (1) · Multiple Sclerosis (1) · ST Elevation Myocardial Infarction (1)
Control Groups (2)
Taiwan (5)
Woei C Shyu (3) · Long Bin Jeng (1) · Wen-Liang Huang (1) · Wen-Liang Huang, MD (1)